Anaphore
About:
Anaphore develops protein therapeutics that address unmet medical needs of patients with life-threatening diseases.
Website: http://www.anaphoreinc.com
Twitter/X: anaphore
Top Investors: 5AM Ventures, SR One, Versant Ventures, M Ventures, Apposite Capital
Description:
Anaphore (formerly ImmunoNewCo) is developing a new class of protein therapeutics to address significant unmet medical needs for patients with serious or life-threatening diseases.
Total Funding Amount:
$54.3M
Headquarters Location:
La Jolla, California, United States
Founded Date:
2008-01-01
Contact Email:
info(AT)anaphoreinc.com
Founders:
Katherine S. Bowdish
Number of Employees:
11-50
Last Funding Date:
2014-03-25
IPO Status:
Private
Industries:
© 2025 bioDAO.ai